Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Atherosclerosis Research

Background:

• Low high-density lipoprotein (HDL)-cholesterol levels correlate with increased coronary artery disease (CAD) and myocardial infarction risk.
• HDL is hypothesized to be anti-atherogenic, possessing properties like promoting cholesterol efflux and endothelial protection.
• Experimental models show mixed effects of increasing HDL-cholesterol on atherosclerosis, suggesting complexity beyond simple levels.

Purpose of the Study:

• To investigate the complex role of HDL in atherosclerosis.
• To understand the heterogeneity and dysfunction of HDL in cardiovascular disease.
• To identify critical HDL functions for anti-atherosclerotic therapies.

Main Methods:

• Review of experimental studies and gene-targeted mouse models.
• Analysis of HDL's vascular effects in healthy individuals and patients with CAD or diabetes.
• Exploration of HDL's biological functions, including cholesterol efflux and endothelial protection.

Main Results:

• HDL exhibits anti-atherogenic properties, including promoting macrophage cholesterol efflux and endothelial protection.
• Increasing HDL-cholesterol levels can have variable effects on atherosclerosis, depending on genetic factors.
• HDL's vascular effects are heterogeneous and impaired in conditions like CAD and diabetes ('HDL dysfunction').

Conclusions:

• Raising HDL-cholesterol levels alone may not be sufficient for effective HDL-targeted therapies.
• Understanding and targeting specific, critical biological functions of HDL is crucial for anti-atherosclerotic strategies.
• Further research is needed to identify and measure these critical HDL functions for therapeutic development.